SlideShare a Scribd company logo
1 of 56
MEDICINAL CHEMISTRY II
B. Pharmacy III/IV (First sem.) PCI syllabus
DR. K. PURNA NAGASREE
M.PHARM. (BITS, PILANI), PH.D., PDF (DST, WOSA)
EX BITS, PILANI FACULTY
DIURETICS
Diuretics
Increase the rate of urine flow and sodium excretion. ADH
 1. Proximal tubule (PT)
 2. Ascending limb of loop of henle (AscLH)
 3. Cortical diluting segment of loop of henle
 4. Distal tubule (DT)
 5. Collecting duct
Nephron
Kidney
 Glomerular filtration
 Tubular Reabsorption
 Tubular Secretion
 GFR = 180 lt./day Male – 120-125ml/min. Female – 105ml/min.
 Urinary output = GFR +Tubular Secretion – Tubular Reabsorption
 Hypertension, Nephritis, Heart failure, Renal failure, oedema
 Glaucoma, migraine, bromide intoxication etc.
CLASSIFICATION (CHEMICAL)
 I. Mercurial diuretics (Mercurous chloride, Mersalyl)
 II. Nonmercurial diuretics
a. Thiazide derivatives - Chlorthiazide*,
Hydrothiazides - Hydrochlorothiazide, Hydroflumethiazide, Cyclothiazide
b. CAse inhibitors - Acetazolamide*, Methazolamide, Dichlorphenamide.
c. Sulphonamide diuretics
e. Aldosterone inhibitors – Spironolactone
f. Pteridine derivatives and related compounds - Triamterene, Amiloride
g. sulphomoyl benzoic acid derivatives - Furosemide*, Bumetanide
h. Phenoxyacetic acid derivatives - Ethacrynic acid
i. Purine or Xanthine derivatives
j. Osmotic diuretics - Mannitol
CLASSIFICATION (Pharmacological)
 Thiazides:Chlorthiazide*, Hydrochlorothiazide, Hydroflumethiazide,
Cyclothiazide
 Carbonic anhydrase inhibitors: Acetazolamide*, Methazolamide,
Dichlorphenamide
 Loop diuretics: Furosemide*, Bumetanide, Ethacrynic acid
 Potassium sparing Diuretics:Spironolactone, Triamterene, Amiloride
 Osmotic Diuretics: Mannitol
Diuretics
 a. Thiazides
i. Chlorthiazide
 Chlorthiazide is a white crystalline powder
 Soluble in dilute solutions of alkali hydroxides, slightly soluble in water
and in alcohol and sparingly soluble in acetone.
 It is a prototype benzothiadiazine derivative
 Used in the treatment of oedema associated With congestive heart
failure, renal, and hepatic disorders.
ii. Hydrochlorthiazide
Hydrochlorthiazide is a white crystalline powder, which is soluble in
acetone and dilute alkali hydroxide solutions, but sparingly soluble in
alcohol.
It is similar to chlorothiazide but It is ten times more potent.
Used in the treatment of oedema associated with congestive heart failure,
renal, and hepatic disorders.
iii. Hydroflumethiazide
Hydroflumethiazide is a white crystalline powder, practically insoluble in
water and ether, soluble in ethanol.
It is a potent oral thiazide diuretic
Used in the management of oedema associated with cardiac failure,
premenstrual tension, and hepatic cirrhosis.
iv. Cyclothiazide
 It exists as white, odourless powder, soluble in alcohol or methanol but
insoluble in water, chloroform, or ether.
 Used as both diuretic and antihypertensive.
SAR of thiazide diuretics
 The 2nd position can tolerate the presence of small alkyl groups such as CH3
 Substituents with hydrophobic character in the 3rd position increases saluretic
activity 1000 times. Substituents include -CH2Cl, -CHCl2, -CH2C6H5, - CH2S, -
CH2, -C6H5
 The increase in saluretic activity - with the lipid solubility.
 Saturation of double bond between the 3rd and 4th
 position of nucleus increases the diuretic activity approximately 3-fold to 10-
fold. Example - Hydrochlorthiazide.
SAR of thiazide diuretics
 Hydrogen atom at the 2nd position is more acidic due to the presence of
neighbouring electron withdrawing sulphone group.
 A free sulphamoyl at 7th position is essential for activity.
 The loss of sulphamoyl group eliminates the diuretic effect, but not the
antihypertensive action
 Direct substitution of the 4th, 5th, or 8th position with an ethyl group
usually results in diminished diuretic activity.
SAR of thiazide diuretics
 Substitution of the 6th position with an activating group is essential for
diuretic activity. The substituents include Cl, Br, and CF3 groups.
 The acidic protons make the formation of water-soluble sodium salt that
can be used for intravenous administration of the diuretics.
Site of
action of
diuretics
Thiazides – DCT
Case inhibitors –
PCT
Loop – TAL
Potasium
sparing –
collecting ducts
Osmotic - PCT
Site of action of diuretics
Mode of action of thiazides and
hydro thiazides
 The sites of action for these drugs are cortical diluting segment or DT.
Here they inhibit Na+ - Cl- symport at the luminal membrane.
 The sodium-chloride symporter (also known as Na+-
Cl− cotransporter, NCC or NCCT, or as the thiazide-sensitive Na+-
Cl− cotransporter or TSC) is a cotransporter in the kidney which has the
function of reabsorbing sodium and chloride ions from the tubular
fluid into the cells of the distal convoluted tubule of the nephron.
MOA
Mode of action of
thiazides and
hydrothiazides:
The sites of action for these
drugs are cortical diluting
segment or DT. Here
they inhibit Na+ - Cl-
symport at the luminal
membrane.
Chlorthiazide synthesis
Uses of thiazide diuretics
 Treatment of hypertension
 Adjunctive therapy in oedema associated with CHF, hepatic cirrhosis,
renal dysfunction, corticosteroid therapy
 To treat nephrogenic diabetes insipidus
 Prevents the formation and recurrence of calcium stones and
nephrolithiasis in hypercalciuric patients
b. Carbonic anhydrase inhibitors
i. Acetazolamide*
Acetazolamide is a white crystalline powder, soluble in dilute alkali hydroxide
solutions, slightly soluble in water and in alcohol.
It is a CAse inhibitor effective for the adjunctive treatment of oedema due to
congestive heart failure, drug induced oedema, chronic simple(open
angled)glaucoma, secondary glaucoma prior to surgery.
Acetazolamide is employed in the treatment petitmal epilepsy.
ii. Methazolamide
Methazolamide is available as white or yellow crystalline powder with a slight odour,
which is soluble in water, in alcohol or in acetone and dimethyl formamide.
It is a more potent CA inhibitor than the prototypic acetazolamide and it is seldom
used as a diuretic.
Methazolamide - improved penetration into the eye, - treatment of glaucoma.
It is employed in the treatment of drug-induced oedema, oedema caused by
congestive heart failure and petitmal epilepsy.
iii. Dichlorphenamide
 It exists as white crystalline powder with a characteristic odour,
soluble in water, sodium hydroxide, alcohol, and ether.
 Used as a diuretic and for the treatment of primary and secondary
glaucoma. It produces less acidotic refractoriness to diuretic action
than acetazolamide.
SAR of CAse Inhibitors
1. Heterocylic sulphonamides
 The C-2 sulphamoyl group is important for activity.
 The free sulphamolyl moiety is necessary to bind with Zn++ in the enzyme; hence,
substitution of sulphamoyl group gives inactive compound.
 The moiety to which the sulphamoyl group is attached must be aromatic in character.
 The heterocyclic sulphonamides with higher partition coefficient and lowest Pka
value have greatest CAse inhibitory and diuretic activities. Example- acetazolamide,
methazolamide.
 N-alkylation with methyl group on ring N- of acetazolamide yields active compound
(methazolamide).
SAR of CAse Inhibitors
2. m-Disulphamoyl benzene derivatives
m-Disulphamoyl benzene do not have diuretic activity.
• Substituted m-sulphamoyl benzene exhibits diuretic activity.
• The unsubstituted sulphamoyl moiety is essential for the activity; any substitution
leads to affect the potency of the compound.
• The sulphamoyl moiety can be replaced with similar electrophilic groups (e.g.
carboxyl, carbamoyl) that may increase the potency of the compound.
• Maximum diuretic activity is obtained when 4th is substituted by Cl, Br, CF3, or NO2
group.
• Substitution of amino group at 6th position increases aleuronic activity, but decreases
CAse inhibitor activity.
Acetazolamide Synthesis
Mode of action of CAse Inhibitors
 CAse is an enzyme that is present in the PT that catalyses the
reversible reaction
H2O + CO2 ↔ H2CO3
 Carbonic acid spontaneously ionizes as H2CO3 - H++ HCO3
-
 CAse inhibitors reversibly inhibits CAse resulting in the slowing of
hydration of CO2 and decrease the availability of H+ to exchange
with luminal Na+ through Na+ - H+ antiporter.
These are weak diuretics cause GI disturbances and fatigue and
replaced by thiazides ( hyperchloremic acidosis)
Mode of action of CAse Inhibitors
Uses of CAse inhibitor diuretics
 Treatment of cystinuria, enhanced excretion of uric acid
 Used in metabolic alkalosis
 used to treat glaucoma
 Used to treat epilepsy and acute altitude sickness
c. High ceiling /Loop diuretics
i. Frusemide or furosemide
Furosemide is a white crystalline powder, practically insoluble in water and in
methylene chloride, soluble in acetone and in dilute solutions of alkali hydroxides,
sparingly soluble in ethanol.
Sulphonamide diuretic. It is slightly more potent than the organomercurial agents, is
orally effective, and its diuretic action is independent of alterations in body acid-base
balance.
It is used for the treatment of oedema associated with renal disease, nephritic
syndrome, Cirrhosis of the liver, and congestive heart failure.
ii Bumetanide
Bumetanide is a white crystalline powder, practically insoluble in water, soluble in
acetone, alcohol, and dilute solutions of alkali hydroxides, slightly soluble in methylene
chloride.
It is a 3-aminobenzoic acid, a potent loop diuretic with efficacy and biochemical effects
similar to those of furosemide.
Used in chronic congestive heart failure, chronic renal failure, chronic hepatic disease,
and in the nephritic syndrome.
It is used in the treatment of renal insufficiency and for The control and management of
acute drug poisoning.
iii. Ethacrynic acid
It exists as a white crystalline powder that is odourless, soluble in alcohol,
ether, or chloroform and in water.
An aryloxyacetic acid derivative that is a potent, short-acting diuretic.
It is used in the treatment of oedema caused by congestive heart failure,
cirrhosis of the liver, and renal disease, including the nephritic syndrome.
(Phenoxyacetic acid derivatives)
SAR of
Loop
Diuretics
They are either 5-sulphamoyl-2-amino benzoic acid (Frusemide) or 5-sulphamoyl-3-
amino benzoic acid (Bumetanide)
 The carbonyl group at C-1 provides optimal diuretic activity.
 The substitution of activating group (X) in the position 4 by Cl, alkoxy, aniline, benzyl,
or benzoyl group increases the diuretic activity.
 The presence of sulphamoyl group in the 5th position is essential for activity.
 The two series of 5-sulphamoyl benzoic acid differ in the nature of the functional
group that substituted in 2nd and 3rd position.
SAR of
Loop
Diuretics The presence of furfuryl, benzyl, and thienyl methyl group at 2nd amino group gives
maximum diuretic activity.
 The wide range of alkyl group can be substituted at 3rd amino group of 5-sulfamoyl-
3-amino benzoic acid without modifying the optimal diuretic activity.
 A molecule with a weakly acidic group to direct the drug to the kidney and an
alkylating moiety to react with sulphydryl groups and lipophilic groups
seemed to provide the best combination of a diuretic in the class.
 5-Sulphamoyl-3-amino benzoic acid derivatives
High ceiling or Loop diuretics
 Mode of action: Na+ -K + 2Cl - co-transporters.
 The Na-K-Cl cotransporter (NKCC) is a protein that aids in the active
transport of sodium, potassium, and chloride - from the urine -
reabsorbed into the blood.
 NKCC with Sodium pump – positive lumen potential - Ca2+ and Mg2+
also reabsorbed
 loop diuretics attach to the chloride-binding site of these proteins to
inhibit reabsorption of Na+ -K + 2Cl - and also Ca2+ and Mg2+.
 Imbalance in water and electrolytes
 Hyponatremia, Hypokalemia, hypocalcemia
Uses
Acute pulmonary oedema
Chronic congestive heart failure
High ceiling
or Loop
diuretics
MOA
Uses of loop diuretics
 Acute pulmonary oedema
 Chronic congestive heart failure
 Treatment of hypertension – no response to thiazides and anti
hypertensives
 Hypercalcemia
 Treatment of hyperkalemia in combination with NaCl
 Used in acute renal failure to increase urine flow and K+
 Treatment of toxic ingestion of bromide, fluoride and iodide (with saline )
d. Potassium-sparing diuretics
i. Spiranolactone (Aldosterone antagonist)
Spironolactone is a white or yellowish-white powder, practically insoluble in water and
soluble in alcohol.
It is a synthetic steroid that acts as a competitive antagonist of the potent, endogenous
mineralocorticosteroid, aldosterone.
It has a slower onset of action than triamterene or amiloride, but its natriuretic effect is
slightly greater during long-term therapy.
It is indicated in the treatment of essential hypertension, oedema associated with
congestive heart failure, hepatic cirrhosis with ascites, the nephritic syndrome and
hypokalemia, and in the diagnosis of primary aldosteronism.
It is useful in the treatment of aldosterone secreting tumours, and high-renin
hypertension.
Spiranolactone (Aldosterone antagonist)
Mode of action
Aldosterone inhibitors inhibit the aldosterone action on mineralocorticoid
receptor, where aldosterone generates aldosterone-induced proteins
along with Na+ K+ ATPase and amiloride sensitive Na+ channels that
leads to the reabsorption of Na+.
Aldosterone inhibitors limit the reabsorption by binding with
mineralocorticoid receptor.
A metabolite of spironolactone, canrenone is also active.
Spiranolactone
(Aldosterone
antagonist)
Mode of
action
ii. Triamterene (Pteridine derivative-
sodium channel blockers)
Triamterene is a yellow crystalline powder, very slightly soluble in water and
alcohol.
It is a pteridine with structural resemblance to folic acid. Replacement of phenyl group
with small basic heterocyclic nucleus such as thiazole and pyridine produces highly
active compounds.
2 and 7 phenyl isomers of triamterene were very potent K + blockers.
Triamterene may be used alone in the treatment of mild oedema associated with
congestive heart failure or cirrhosis of the liver with ascites.
It is used in the treatment of oedema associated with nephritic syndrome, cirrhosis of
liver and Congestive heart failure.
iii. Amiloride (Pteridine derivative -
sodium channel blockers)
Amiloride hydrochloride is a pale-yellow to greenish-yellow powder, slightly soluble
in water and in anhydrous ethanol.
It is a potassium-conserving drug with natriuretic diuretic and antihypertensive
activity.
It is an aminopyrazine, Considered an open chain analogue of triamterene.
It blocks the reabsorption of sodium ion and the secretion of potassium ion. Amiloride
is more potent than triamterene.
Potassium sparing diuretics (Pteridine derivatives MOA)
 These drugs act on Na+ channel from the luminal side and block the
actions.
 Thus, it reduces the lumen negative transepithelial potential
difference, which governs K+ and H+ secretion
Uses of Potassium sparing
diuretics Used in combination with loop diuretics and thiazides in treatment of
oedema and hypertension
 Pseudo hyperaldosteronism (Liddle’s syndrome)
 To treat oedema associated with secondary hyperaldosteronism
 Spironolactone is diuretic of choice in patients with hepatic cirrhosis
 Amiloride is used to treat lithium induced nephrogenic diabetes
e. Osmotic Diuretics
i. Mannitol
 Osmotic diuretics are non electrolytes, which are freely filtered at the
glomerulus and are not significantly reabsorbed from the tubules
 Presence of these agents in the urine causes an increase in the electrolytes and
volume flow.
 Mannitol, urea, glycerol, and isosorbide are the four osmotic diuretics, which are
freely filtered through the glomerulus and are insignificantly reabsorbed from the
tubules
 They mainly induce diuresis by inhibiting sodium and water reabsorption in the PTs
and the henle’s loop.
Osmotic
Diuretics
Mannitol
Mode of
action
Uses of osmotic diuretics
 Management of cerebral oedema
 Diagnostic agent for kidney function (mannitol)
 To increase urine volume in few patients with acute renal failure due to
ischemia, nephrotoxins, haemoglobinuria and myoglobinuria
 To reduce intraocular pressure (glycerine and isosorbide)
 To reduce CSF pressure and volume
 To reduce intracranial pressure before and after neurosurgery
CLASSIFICATION (Pharmacological)
 Thiazides:Chlorthiazide*, Hydrochlorothiazide, Hydroflumethiazide,
Cyclothiazide
 Carbonic anhydrase inhibitors: Acetazolamide*, Methazolamide,
Dichlorphenamide
 Loop diuretics: Furosemide*, Bumetanide, Ethacrynic acid
 Potassium sparing Diuretics:Spironolactone, Triamterene, Amiloride
 Osmotic Diuretics: Mannitol
Summary - Synthesis
Summary - MOA
Summary - MOA
Summary - SAR
Summary - SAR

More Related Content

What's hot

What's hot (20)

Antidiabetic agents-medicinal chemistry
Antidiabetic agents-medicinal chemistryAntidiabetic agents-medicinal chemistry
Antidiabetic agents-medicinal chemistry
 
2. phenylpropanoids and flavonoids
2. phenylpropanoids and flavonoids2. phenylpropanoids and flavonoids
2. phenylpropanoids and flavonoids
 
Pharmacognosy- Glycosides
Pharmacognosy- GlycosidesPharmacognosy- Glycosides
Pharmacognosy- Glycosides
 
Bitter almond
Bitter almondBitter almond
Bitter almond
 
Congestive heart failure (chf) medicinal chemistry
Congestive heart failure (chf) medicinal chemistryCongestive heart failure (chf) medicinal chemistry
Congestive heart failure (chf) medicinal chemistry
 
Isolation,identification and analysis of phytoconstituents. Dr.U.Srinivasa, P...
Isolation,identification and analysis of phytoconstituents. Dr.U.Srinivasa, P...Isolation,identification and analysis of phytoconstituents. Dr.U.Srinivasa, P...
Isolation,identification and analysis of phytoconstituents. Dr.U.Srinivasa, P...
 
Calcium channel blockers - Medicinal chemistry for B.Pharm.
Calcium channel blockers - Medicinal chemistry for B.Pharm.Calcium channel blockers - Medicinal chemistry for B.Pharm.
Calcium channel blockers - Medicinal chemistry for B.Pharm.
 
Thyroid and antithyroid drugs- medicinal chemistry
Thyroid and antithyroid drugs- medicinal chemistryThyroid and antithyroid drugs- medicinal chemistry
Thyroid and antithyroid drugs- medicinal chemistry
 
Lipids (Pharmacognosy) MANIK
Lipids (Pharmacognosy) MANIKLipids (Pharmacognosy) MANIK
Lipids (Pharmacognosy) MANIK
 
2.nomenclature of steroids
2.nomenclature of steroids2.nomenclature of steroids
2.nomenclature of steroids
 
Enzymes in pharmacognosy
Enzymes in pharmacognosyEnzymes in pharmacognosy
Enzymes in pharmacognosy
 
Antihistaminics-Medicinal Chemistry
Antihistaminics-Medicinal ChemistryAntihistaminics-Medicinal Chemistry
Antihistaminics-Medicinal Chemistry
 
5th unit local anaesthetics
5th unit local anaesthetics5th unit local anaesthetics
5th unit local anaesthetics
 
Histamine &antihistaminic agents
Histamine &antihistaminic agentsHistamine &antihistaminic agents
Histamine &antihistaminic agents
 
3rd unit anti-hyperlipidemic agents ppt
3rd  unit  anti-hyperlipidemic  agents ppt3rd  unit  anti-hyperlipidemic  agents ppt
3rd unit anti-hyperlipidemic agents ppt
 
PTEROCARPUS- TANNINS
PTEROCARPUS- TANNINSPTEROCARPUS- TANNINS
PTEROCARPUS- TANNINS
 
ANTI HYPERTENSIVE AGENTS [MEDICINAL CHEMISTRY] BY P.RAVISANKAR, HYPERTENSION,...
ANTI HYPERTENSIVE AGENTS [MEDICINAL CHEMISTRY] BY P.RAVISANKAR, HYPERTENSION,...ANTI HYPERTENSIVE AGENTS [MEDICINAL CHEMISTRY] BY P.RAVISANKAR, HYPERTENSION,...
ANTI HYPERTENSIVE AGENTS [MEDICINAL CHEMISTRY] BY P.RAVISANKAR, HYPERTENSION,...
 
Acetate mevalonate pathway
Acetate mevalonate pathwayAcetate mevalonate pathway
Acetate mevalonate pathway
 
Isolation, Identification and Analysis of Phytoconstituents
Isolation, Identification and Analysis of PhytoconstituentsIsolation, Identification and Analysis of Phytoconstituents
Isolation, Identification and Analysis of Phytoconstituents
 
ACE Inhibitors
ACE InhibitorsACE Inhibitors
ACE Inhibitors
 

Similar to Diuretics scribd

Similar to Diuretics scribd (20)

diuretics.pptx
diuretics.pptxdiuretics.pptx
diuretics.pptx
 
Diuretics
DiureticsDiuretics
Diuretics
 
UME - Diuretics .pdf
UME - Diuretics .pdfUME - Diuretics .pdf
UME - Diuretics .pdf
 
Diuretics and CVS.pptx
Diuretics and CVS.pptxDiuretics and CVS.pptx
Diuretics and CVS.pptx
 
Diuretics
DiureticsDiuretics
Diuretics
 
Renal-Diuretics.pdf
Renal-Diuretics.pdfRenal-Diuretics.pdf
Renal-Diuretics.pdf
 
6 diuretic
6 diuretic6 diuretic
6 diuretic
 
Diuretics
DiureticsDiuretics
Diuretics
 
Diuretics presentation by DVM student Hamza Jawad
Diuretics presentation by DVM student Hamza JawadDiuretics presentation by DVM student Hamza Jawad
Diuretics presentation by DVM student Hamza Jawad
 
Anti anginals & diuretics
Anti anginals & diuretics Anti anginals & diuretics
Anti anginals & diuretics
 
Diureticsvpp
DiureticsvppDiureticsvpp
Diureticsvpp
 
Pharmacology of Diuretics
Pharmacology of DiureticsPharmacology of Diuretics
Pharmacology of Diuretics
 
Medicinal diuretics by Waris Nawaz
Medicinal diuretics by Waris NawazMedicinal diuretics by Waris Nawaz
Medicinal diuretics by Waris Nawaz
 
Diuretics
DiureticsDiuretics
Diuretics
 
Diuretics new
Diuretics newDiuretics new
Diuretics new
 
Diuretics
DiureticsDiuretics
Diuretics
 
Diuretics by P.Ravisankar
Diuretics by P.RavisankarDiuretics by P.Ravisankar
Diuretics by P.Ravisankar
 
Diuretics
DiureticsDiuretics
Diuretics
 
Diuretic
Diuretic Diuretic
Diuretic
 
Diuretics and antidiuretics detail STUDY
Diuretics and antidiuretics detail STUDYDiuretics and antidiuretics detail STUDY
Diuretics and antidiuretics detail STUDY
 

More from Purna Nagasree K

More from Purna Nagasree K (11)

CNS - Antipsychotics
CNS -  AntipsychoticsCNS -  Antipsychotics
CNS - Antipsychotics
 
CNS- anticonvulsants or Antiepileptics
CNS-  anticonvulsants or AntiepilepticsCNS-  anticonvulsants or Antiepileptics
CNS- anticonvulsants or Antiepileptics
 
Antiobiotics - Macrolides and miscellaneous
Antiobiotics - Macrolides and miscellaneousAntiobiotics - Macrolides and miscellaneous
Antiobiotics - Macrolides and miscellaneous
 
Antibiotics - Aminoglycosides
Antibiotics - AminoglycosidesAntibiotics - Aminoglycosides
Antibiotics - Aminoglycosides
 
Antibiotics - Beta lactam antibiotics, PCI syllabus for B.Pharm.
Antibiotics - Beta lactam antibiotics, PCI syllabus for B.Pharm.Antibiotics - Beta lactam antibiotics, PCI syllabus for B.Pharm.
Antibiotics - Beta lactam antibiotics, PCI syllabus for B.Pharm.
 
Beta lactam antibiotics, PCI syllabus for B.Pharm.
Beta lactam antibiotics, PCI syllabus for B.Pharm.Beta lactam antibiotics, PCI syllabus for B.Pharm.
Beta lactam antibiotics, PCI syllabus for B.Pharm.
 
Med chem hypnotics and sedatives
Med chem hypnotics and sedatives Med chem hypnotics and sedatives
Med chem hypnotics and sedatives
 
Anti hypertensives scribd
Anti hypertensives  scribdAnti hypertensives  scribd
Anti hypertensives scribd
 
Hypnotics and sedatives slideshare
Hypnotics and sedatives   slideshareHypnotics and sedatives   slideshare
Hypnotics and sedatives slideshare
 
Antipsychotics scribdt
Antipsychotics   scribdtAntipsychotics   scribdt
Antipsychotics scribdt
 
Vasodilators - Medicinal chemistry for B.Pharm.
Vasodilators - Medicinal chemistry for B.Pharm.Vasodilators - Medicinal chemistry for B.Pharm.
Vasodilators - Medicinal chemistry for B.Pharm.
 

Recently uploaded

QUATER-1-PE-HEALTH-LC2- this is just a sample of unpacked lesson
QUATER-1-PE-HEALTH-LC2- this is just a sample of unpacked lessonQUATER-1-PE-HEALTH-LC2- this is just a sample of unpacked lesson
QUATER-1-PE-HEALTH-LC2- this is just a sample of unpacked lesson
httgc7rh9c
 

Recently uploaded (20)

Model Attribute _rec_name in the Odoo 17
Model Attribute _rec_name in the Odoo 17Model Attribute _rec_name in the Odoo 17
Model Attribute _rec_name in the Odoo 17
 
How to setup Pycharm environment for Odoo 17.pptx
How to setup Pycharm environment for Odoo 17.pptxHow to setup Pycharm environment for Odoo 17.pptx
How to setup Pycharm environment for Odoo 17.pptx
 
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptxHMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
 
What is 3 Way Matching Process in Odoo 17.pptx
What is 3 Way Matching Process in Odoo 17.pptxWhat is 3 Way Matching Process in Odoo 17.pptx
What is 3 Way Matching Process in Odoo 17.pptx
 
On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan Fellows
 
Economic Importance Of Fungi In Food Additives
Economic Importance Of Fungi In Food AdditivesEconomic Importance Of Fungi In Food Additives
Economic Importance Of Fungi In Food Additives
 
PANDITA RAMABAI- Indian political thought GENDER.pptx
PANDITA RAMABAI- Indian political thought GENDER.pptxPANDITA RAMABAI- Indian political thought GENDER.pptx
PANDITA RAMABAI- Indian political thought GENDER.pptx
 
Simple, Complex, and Compound Sentences Exercises.pdf
Simple, Complex, and Compound Sentences Exercises.pdfSimple, Complex, and Compound Sentences Exercises.pdf
Simple, Complex, and Compound Sentences Exercises.pdf
 
NO1 Top Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...
NO1 Top Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...NO1 Top Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...
NO1 Top Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...
 
Exploring_the_Narrative_Style_of_Amitav_Ghoshs_Gun_Island.pptx
Exploring_the_Narrative_Style_of_Amitav_Ghoshs_Gun_Island.pptxExploring_the_Narrative_Style_of_Amitav_Ghoshs_Gun_Island.pptx
Exploring_the_Narrative_Style_of_Amitav_Ghoshs_Gun_Island.pptx
 
AIM of Education-Teachers Training-2024.ppt
AIM of Education-Teachers Training-2024.pptAIM of Education-Teachers Training-2024.ppt
AIM of Education-Teachers Training-2024.ppt
 
dusjagr & nano talk on open tools for agriculture research and learning
dusjagr & nano talk on open tools for agriculture research and learningdusjagr & nano talk on open tools for agriculture research and learning
dusjagr & nano talk on open tools for agriculture research and learning
 
21st_Century_Skills_Framework_Final_Presentation_2.pptx
21st_Century_Skills_Framework_Final_Presentation_2.pptx21st_Century_Skills_Framework_Final_Presentation_2.pptx
21st_Century_Skills_Framework_Final_Presentation_2.pptx
 
REMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptxREMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptx
 
Play hard learn harder: The Serious Business of Play
Play hard learn harder:  The Serious Business of PlayPlay hard learn harder:  The Serious Business of Play
Play hard learn harder: The Serious Business of Play
 
COMMUNICATING NEGATIVE NEWS - APPROACHES .pptx
COMMUNICATING NEGATIVE NEWS - APPROACHES .pptxCOMMUNICATING NEGATIVE NEWS - APPROACHES .pptx
COMMUNICATING NEGATIVE NEWS - APPROACHES .pptx
 
QUATER-1-PE-HEALTH-LC2- this is just a sample of unpacked lesson
QUATER-1-PE-HEALTH-LC2- this is just a sample of unpacked lessonQUATER-1-PE-HEALTH-LC2- this is just a sample of unpacked lesson
QUATER-1-PE-HEALTH-LC2- this is just a sample of unpacked lesson
 
Jamworks pilot and AI at Jisc (20/03/2024)
Jamworks pilot and AI at Jisc (20/03/2024)Jamworks pilot and AI at Jisc (20/03/2024)
Jamworks pilot and AI at Jisc (20/03/2024)
 
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...
 
How to Add New Custom Addons Path in Odoo 17
How to Add New Custom Addons Path in Odoo 17How to Add New Custom Addons Path in Odoo 17
How to Add New Custom Addons Path in Odoo 17
 

Diuretics scribd

  • 1. MEDICINAL CHEMISTRY II B. Pharmacy III/IV (First sem.) PCI syllabus DR. K. PURNA NAGASREE M.PHARM. (BITS, PILANI), PH.D., PDF (DST, WOSA) EX BITS, PILANI FACULTY
  • 3. Diuretics Increase the rate of urine flow and sodium excretion. ADH  1. Proximal tubule (PT)  2. Ascending limb of loop of henle (AscLH)  3. Cortical diluting segment of loop of henle  4. Distal tubule (DT)  5. Collecting duct
  • 5.  Glomerular filtration  Tubular Reabsorption  Tubular Secretion  GFR = 180 lt./day Male – 120-125ml/min. Female – 105ml/min.  Urinary output = GFR +Tubular Secretion – Tubular Reabsorption  Hypertension, Nephritis, Heart failure, Renal failure, oedema  Glaucoma, migraine, bromide intoxication etc.
  • 6. CLASSIFICATION (CHEMICAL)  I. Mercurial diuretics (Mercurous chloride, Mersalyl)  II. Nonmercurial diuretics a. Thiazide derivatives - Chlorthiazide*, Hydrothiazides - Hydrochlorothiazide, Hydroflumethiazide, Cyclothiazide b. CAse inhibitors - Acetazolamide*, Methazolamide, Dichlorphenamide. c. Sulphonamide diuretics e. Aldosterone inhibitors – Spironolactone f. Pteridine derivatives and related compounds - Triamterene, Amiloride g. sulphomoyl benzoic acid derivatives - Furosemide*, Bumetanide h. Phenoxyacetic acid derivatives - Ethacrynic acid i. Purine or Xanthine derivatives j. Osmotic diuretics - Mannitol
  • 7. CLASSIFICATION (Pharmacological)  Thiazides:Chlorthiazide*, Hydrochlorothiazide, Hydroflumethiazide, Cyclothiazide  Carbonic anhydrase inhibitors: Acetazolamide*, Methazolamide, Dichlorphenamide  Loop diuretics: Furosemide*, Bumetanide, Ethacrynic acid  Potassium sparing Diuretics:Spironolactone, Triamterene, Amiloride  Osmotic Diuretics: Mannitol
  • 8. Diuretics  a. Thiazides i. Chlorthiazide  Chlorthiazide is a white crystalline powder  Soluble in dilute solutions of alkali hydroxides, slightly soluble in water and in alcohol and sparingly soluble in acetone.  It is a prototype benzothiadiazine derivative  Used in the treatment of oedema associated With congestive heart failure, renal, and hepatic disorders.
  • 9. ii. Hydrochlorthiazide Hydrochlorthiazide is a white crystalline powder, which is soluble in acetone and dilute alkali hydroxide solutions, but sparingly soluble in alcohol. It is similar to chlorothiazide but It is ten times more potent. Used in the treatment of oedema associated with congestive heart failure, renal, and hepatic disorders.
  • 10. iii. Hydroflumethiazide Hydroflumethiazide is a white crystalline powder, practically insoluble in water and ether, soluble in ethanol. It is a potent oral thiazide diuretic Used in the management of oedema associated with cardiac failure, premenstrual tension, and hepatic cirrhosis.
  • 11. iv. Cyclothiazide  It exists as white, odourless powder, soluble in alcohol or methanol but insoluble in water, chloroform, or ether.  Used as both diuretic and antihypertensive.
  • 12. SAR of thiazide diuretics  The 2nd position can tolerate the presence of small alkyl groups such as CH3  Substituents with hydrophobic character in the 3rd position increases saluretic activity 1000 times. Substituents include -CH2Cl, -CHCl2, -CH2C6H5, - CH2S, - CH2, -C6H5  The increase in saluretic activity - with the lipid solubility.  Saturation of double bond between the 3rd and 4th  position of nucleus increases the diuretic activity approximately 3-fold to 10- fold. Example - Hydrochlorthiazide.
  • 13. SAR of thiazide diuretics  Hydrogen atom at the 2nd position is more acidic due to the presence of neighbouring electron withdrawing sulphone group.  A free sulphamoyl at 7th position is essential for activity.  The loss of sulphamoyl group eliminates the diuretic effect, but not the antihypertensive action  Direct substitution of the 4th, 5th, or 8th position with an ethyl group usually results in diminished diuretic activity.
  • 14. SAR of thiazide diuretics  Substitution of the 6th position with an activating group is essential for diuretic activity. The substituents include Cl, Br, and CF3 groups.  The acidic protons make the formation of water-soluble sodium salt that can be used for intravenous administration of the diuretics.
  • 15. Site of action of diuretics Thiazides – DCT Case inhibitors – PCT Loop – TAL Potasium sparing – collecting ducts Osmotic - PCT
  • 16. Site of action of diuretics
  • 17. Mode of action of thiazides and hydro thiazides  The sites of action for these drugs are cortical diluting segment or DT. Here they inhibit Na+ - Cl- symport at the luminal membrane.  The sodium-chloride symporter (also known as Na+- Cl− cotransporter, NCC or NCCT, or as the thiazide-sensitive Na+- Cl− cotransporter or TSC) is a cotransporter in the kidney which has the function of reabsorbing sodium and chloride ions from the tubular fluid into the cells of the distal convoluted tubule of the nephron.
  • 18. MOA
  • 19. Mode of action of thiazides and hydrothiazides: The sites of action for these drugs are cortical diluting segment or DT. Here they inhibit Na+ - Cl- symport at the luminal membrane.
  • 21. Uses of thiazide diuretics  Treatment of hypertension  Adjunctive therapy in oedema associated with CHF, hepatic cirrhosis, renal dysfunction, corticosteroid therapy  To treat nephrogenic diabetes insipidus  Prevents the formation and recurrence of calcium stones and nephrolithiasis in hypercalciuric patients
  • 22. b. Carbonic anhydrase inhibitors i. Acetazolamide* Acetazolamide is a white crystalline powder, soluble in dilute alkali hydroxide solutions, slightly soluble in water and in alcohol. It is a CAse inhibitor effective for the adjunctive treatment of oedema due to congestive heart failure, drug induced oedema, chronic simple(open angled)glaucoma, secondary glaucoma prior to surgery. Acetazolamide is employed in the treatment petitmal epilepsy.
  • 23. ii. Methazolamide Methazolamide is available as white or yellow crystalline powder with a slight odour, which is soluble in water, in alcohol or in acetone and dimethyl formamide. It is a more potent CA inhibitor than the prototypic acetazolamide and it is seldom used as a diuretic. Methazolamide - improved penetration into the eye, - treatment of glaucoma. It is employed in the treatment of drug-induced oedema, oedema caused by congestive heart failure and petitmal epilepsy.
  • 24. iii. Dichlorphenamide  It exists as white crystalline powder with a characteristic odour, soluble in water, sodium hydroxide, alcohol, and ether.  Used as a diuretic and for the treatment of primary and secondary glaucoma. It produces less acidotic refractoriness to diuretic action than acetazolamide.
  • 25. SAR of CAse Inhibitors 1. Heterocylic sulphonamides  The C-2 sulphamoyl group is important for activity.  The free sulphamolyl moiety is necessary to bind with Zn++ in the enzyme; hence, substitution of sulphamoyl group gives inactive compound.  The moiety to which the sulphamoyl group is attached must be aromatic in character.  The heterocyclic sulphonamides with higher partition coefficient and lowest Pka value have greatest CAse inhibitory and diuretic activities. Example- acetazolamide, methazolamide.  N-alkylation with methyl group on ring N- of acetazolamide yields active compound (methazolamide).
  • 26.
  • 27. SAR of CAse Inhibitors 2. m-Disulphamoyl benzene derivatives m-Disulphamoyl benzene do not have diuretic activity. • Substituted m-sulphamoyl benzene exhibits diuretic activity. • The unsubstituted sulphamoyl moiety is essential for the activity; any substitution leads to affect the potency of the compound. • The sulphamoyl moiety can be replaced with similar electrophilic groups (e.g. carboxyl, carbamoyl) that may increase the potency of the compound. • Maximum diuretic activity is obtained when 4th is substituted by Cl, Br, CF3, or NO2 group. • Substitution of amino group at 6th position increases aleuronic activity, but decreases CAse inhibitor activity.
  • 29. Mode of action of CAse Inhibitors  CAse is an enzyme that is present in the PT that catalyses the reversible reaction H2O + CO2 ↔ H2CO3  Carbonic acid spontaneously ionizes as H2CO3 - H++ HCO3 -  CAse inhibitors reversibly inhibits CAse resulting in the slowing of hydration of CO2 and decrease the availability of H+ to exchange with luminal Na+ through Na+ - H+ antiporter. These are weak diuretics cause GI disturbances and fatigue and replaced by thiazides ( hyperchloremic acidosis)
  • 30. Mode of action of CAse Inhibitors
  • 31. Uses of CAse inhibitor diuretics  Treatment of cystinuria, enhanced excretion of uric acid  Used in metabolic alkalosis  used to treat glaucoma  Used to treat epilepsy and acute altitude sickness
  • 32. c. High ceiling /Loop diuretics i. Frusemide or furosemide Furosemide is a white crystalline powder, practically insoluble in water and in methylene chloride, soluble in acetone and in dilute solutions of alkali hydroxides, sparingly soluble in ethanol. Sulphonamide diuretic. It is slightly more potent than the organomercurial agents, is orally effective, and its diuretic action is independent of alterations in body acid-base balance. It is used for the treatment of oedema associated with renal disease, nephritic syndrome, Cirrhosis of the liver, and congestive heart failure.
  • 33. ii Bumetanide Bumetanide is a white crystalline powder, practically insoluble in water, soluble in acetone, alcohol, and dilute solutions of alkali hydroxides, slightly soluble in methylene chloride. It is a 3-aminobenzoic acid, a potent loop diuretic with efficacy and biochemical effects similar to those of furosemide. Used in chronic congestive heart failure, chronic renal failure, chronic hepatic disease, and in the nephritic syndrome. It is used in the treatment of renal insufficiency and for The control and management of acute drug poisoning.
  • 34. iii. Ethacrynic acid It exists as a white crystalline powder that is odourless, soluble in alcohol, ether, or chloroform and in water. An aryloxyacetic acid derivative that is a potent, short-acting diuretic. It is used in the treatment of oedema caused by congestive heart failure, cirrhosis of the liver, and renal disease, including the nephritic syndrome. (Phenoxyacetic acid derivatives)
  • 35. SAR of Loop Diuretics They are either 5-sulphamoyl-2-amino benzoic acid (Frusemide) or 5-sulphamoyl-3- amino benzoic acid (Bumetanide)  The carbonyl group at C-1 provides optimal diuretic activity.  The substitution of activating group (X) in the position 4 by Cl, alkoxy, aniline, benzyl, or benzoyl group increases the diuretic activity.  The presence of sulphamoyl group in the 5th position is essential for activity.  The two series of 5-sulphamoyl benzoic acid differ in the nature of the functional group that substituted in 2nd and 3rd position.
  • 36. SAR of Loop Diuretics The presence of furfuryl, benzyl, and thienyl methyl group at 2nd amino group gives maximum diuretic activity.  The wide range of alkyl group can be substituted at 3rd amino group of 5-sulfamoyl- 3-amino benzoic acid without modifying the optimal diuretic activity.  A molecule with a weakly acidic group to direct the drug to the kidney and an alkylating moiety to react with sulphydryl groups and lipophilic groups seemed to provide the best combination of a diuretic in the class.  5-Sulphamoyl-3-amino benzoic acid derivatives
  • 37. High ceiling or Loop diuretics  Mode of action: Na+ -K + 2Cl - co-transporters.  The Na-K-Cl cotransporter (NKCC) is a protein that aids in the active transport of sodium, potassium, and chloride - from the urine - reabsorbed into the blood.  NKCC with Sodium pump – positive lumen potential - Ca2+ and Mg2+ also reabsorbed  loop diuretics attach to the chloride-binding site of these proteins to inhibit reabsorption of Na+ -K + 2Cl - and also Ca2+ and Mg2+.
  • 38.  Imbalance in water and electrolytes  Hyponatremia, Hypokalemia, hypocalcemia Uses Acute pulmonary oedema Chronic congestive heart failure
  • 40. Uses of loop diuretics  Acute pulmonary oedema  Chronic congestive heart failure  Treatment of hypertension – no response to thiazides and anti hypertensives  Hypercalcemia  Treatment of hyperkalemia in combination with NaCl  Used in acute renal failure to increase urine flow and K+  Treatment of toxic ingestion of bromide, fluoride and iodide (with saline )
  • 41. d. Potassium-sparing diuretics i. Spiranolactone (Aldosterone antagonist) Spironolactone is a white or yellowish-white powder, practically insoluble in water and soluble in alcohol. It is a synthetic steroid that acts as a competitive antagonist of the potent, endogenous mineralocorticosteroid, aldosterone. It has a slower onset of action than triamterene or amiloride, but its natriuretic effect is slightly greater during long-term therapy. It is indicated in the treatment of essential hypertension, oedema associated with congestive heart failure, hepatic cirrhosis with ascites, the nephritic syndrome and hypokalemia, and in the diagnosis of primary aldosteronism. It is useful in the treatment of aldosterone secreting tumours, and high-renin hypertension.
  • 42. Spiranolactone (Aldosterone antagonist) Mode of action Aldosterone inhibitors inhibit the aldosterone action on mineralocorticoid receptor, where aldosterone generates aldosterone-induced proteins along with Na+ K+ ATPase and amiloride sensitive Na+ channels that leads to the reabsorption of Na+. Aldosterone inhibitors limit the reabsorption by binding with mineralocorticoid receptor. A metabolite of spironolactone, canrenone is also active.
  • 44. ii. Triamterene (Pteridine derivative- sodium channel blockers) Triamterene is a yellow crystalline powder, very slightly soluble in water and alcohol. It is a pteridine with structural resemblance to folic acid. Replacement of phenyl group with small basic heterocyclic nucleus such as thiazole and pyridine produces highly active compounds. 2 and 7 phenyl isomers of triamterene were very potent K + blockers. Triamterene may be used alone in the treatment of mild oedema associated with congestive heart failure or cirrhosis of the liver with ascites. It is used in the treatment of oedema associated with nephritic syndrome, cirrhosis of liver and Congestive heart failure.
  • 45. iii. Amiloride (Pteridine derivative - sodium channel blockers) Amiloride hydrochloride is a pale-yellow to greenish-yellow powder, slightly soluble in water and in anhydrous ethanol. It is a potassium-conserving drug with natriuretic diuretic and antihypertensive activity. It is an aminopyrazine, Considered an open chain analogue of triamterene. It blocks the reabsorption of sodium ion and the secretion of potassium ion. Amiloride is more potent than triamterene.
  • 46. Potassium sparing diuretics (Pteridine derivatives MOA)  These drugs act on Na+ channel from the luminal side and block the actions.  Thus, it reduces the lumen negative transepithelial potential difference, which governs K+ and H+ secretion
  • 47. Uses of Potassium sparing diuretics Used in combination with loop diuretics and thiazides in treatment of oedema and hypertension  Pseudo hyperaldosteronism (Liddle’s syndrome)  To treat oedema associated with secondary hyperaldosteronism  Spironolactone is diuretic of choice in patients with hepatic cirrhosis  Amiloride is used to treat lithium induced nephrogenic diabetes
  • 48. e. Osmotic Diuretics i. Mannitol  Osmotic diuretics are non electrolytes, which are freely filtered at the glomerulus and are not significantly reabsorbed from the tubules  Presence of these agents in the urine causes an increase in the electrolytes and volume flow.  Mannitol, urea, glycerol, and isosorbide are the four osmotic diuretics, which are freely filtered through the glomerulus and are insignificantly reabsorbed from the tubules  They mainly induce diuresis by inhibiting sodium and water reabsorption in the PTs and the henle’s loop.
  • 50. Uses of osmotic diuretics  Management of cerebral oedema  Diagnostic agent for kidney function (mannitol)  To increase urine volume in few patients with acute renal failure due to ischemia, nephrotoxins, haemoglobinuria and myoglobinuria  To reduce intraocular pressure (glycerine and isosorbide)  To reduce CSF pressure and volume  To reduce intracranial pressure before and after neurosurgery
  • 51. CLASSIFICATION (Pharmacological)  Thiazides:Chlorthiazide*, Hydrochlorothiazide, Hydroflumethiazide, Cyclothiazide  Carbonic anhydrase inhibitors: Acetazolamide*, Methazolamide, Dichlorphenamide  Loop diuretics: Furosemide*, Bumetanide, Ethacrynic acid  Potassium sparing Diuretics:Spironolactone, Triamterene, Amiloride  Osmotic Diuretics: Mannitol

Editor's Notes

  1. CLC-K: Voltage-gated chloride channel; TRPV5: Transient receptor potential cation channel subfamily 5 (a calcium selective channel).
  2. Furan , furfural, furfuryl alcohol
  3. Nephritic syndrome is the name given to a collection of different signs and symptoms that occur as a result of inflammation in the kidneys. This inflammation causes the kidneys to work less effectively. It also causes protein and red blood cells to leak from the bloodstream into the urine. Renal insufficiency is poor function of the kidneys that may be due to a reduction in blood-flow to the kidneys caused by renal artery disease. Normally, the kidneys regulate body fluid and blood pressure, as well as regulate blood chemistry and remove organic waste. Chronic renal failure, or chronic kidney disease (CKD), is a slow and progressive decline of kidney function. It's usually a result of a complication from another serious medical condition such as diabetes, high blood pressure or cardiovascular disease. Cirrhosis is when scar tissue replaces healthy liver tissue. This stops the liver from working normally. Cirrhosis is a long-term (chronic) liver disease. The most common causes are hepatitis and other viruses, and alcohol abuse. Other medical problems can also cause it. Heart failure, sometimes known as congestive heart failure, occurs when your heart muscle doesn't pump blood as well as it should. Certain conditions, such as narrowed arteries in your heart (coronary artery disease) or high blood pressure, gradually leave your heart too weak or stiff to fill and pump efficiently.
  4. Ascites - the accumulation of fluid in the peritoneal cavity, causing abdominal swelling. Primary aldosteronism  is a hormonal disorder that leads to high blood pressure. It occurs when your adrenal glands produce too much of a hormone called aldosterone. Your adrenal glands produce a number of essential hormones, including aldosterone. aldosterone secreting tumours – could lead to hyperaldosteronism ie primary or secondary...
  5. −C(=NH)NH2 characteristic of an amidine.